<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?" class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f6/4049437/a79cb8facd5d/1471-2407-14-395-1.jpg"/> </div> <div class="text-side"> <h1>Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?</h1> <p>Immunostaining for E-cadherin. A) Immunostaining for E-cadherin in normal oral mucosa. B) Strong membranous immunostaining in the oral basaloid squamous cell carcinoma (BSCC). C) Most neoplastic cells of well to moderately differentiated squamous cell carcinoma (W/MSCC) showed strong membranous immunopositivity. D) Poorly differentiated squamous cell carcinoma (PDSCC) showed weak membranous immunostaining. (A, B, C and D, immunohistochemistry E-cadherin; original magnifications, A, B and D, ×400; C, ×100).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24893577/" target="_blank">24893577</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>